Helicobacter pylori: molecular basis for colonization and survival in gastric environment and resistance to antibiotics. A short review.


Journal

Infectious diseases (London, England)
ISSN: 2374-4243
Titre abrégé: Infect Dis (Lond)
Pays: England
ID NLM: 101650235

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 26 3 2019
medline: 21 12 2019
entrez: 26 3 2019
Statut: ppublish

Résumé

Helicobacter pylori is a human-specific pathogen with a strict tropism for the gastric mucosa. This bacterium infects around half of the world population and is the main responsible for gastritis, peptic ulcer and, in some cases, for the pathogenesis of gastric cancer. Nevertheless, disease development in infected subjects depends not only on the bacterium, but also on the host genetic predisposition and on environmental factors. The fascinating question of how the bacterium can survive in the gastric environment has stimulated research in this field. It is now clear that H. pylori is able to colonize and adhere to the gastric epithelium through several mechanisms, including the breakdown of urea with production of the cell-toxic ammonia. The resulting raise in pH neutralizes acidity of the stomach, thereby allowing the bacterium to safely cross the mucus layer to the epithelial surface. Current challenges regard understanding the mechanisms of antibiotic resistance and how to overcome it. Lately, an increasing H. pylori resistance rate to antibiotics has been reported and several molecular bases for this phenomenon described. In this review, we highlight the current knowledge on mechanisms supporting H. pylori resistance to gastric environment and to therapy.

Identifiants

pubmed: 30907202
doi: 10.1080/23744235.2019.1588472
doi:

Substances chimiques

Urea 8W8T17847W

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-408

Auteurs

Sharmila Fagoonee (S)

a Institute for Biostructure and Bioimaging (CNR) c/o Molecular Biotechnology Center , Turin , Italy.

Rinaldo Pellicano (R)

b Unit of Gastroenterology , Molinette-SGAS Hospital , Turin , Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH